InnoCan Pharma Corporation (CSE:INNO)
8.34
+0.34 (4.25%)
At close: Feb 20, 2026
-37.41% (1Y)
| Market Cap | 37.52M -37.7% |
| Revenue (ttm) | 37.64M -6.6% |
| Net Income | -4.50M |
| EPS | -1.01 |
| Shares Out | 4.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,115 |
| Average Volume | 2,250 |
| Open | 8.10 |
| Previous Close | 8.00 |
| Day's Range | 8.10 - 8.34 |
| 52-Week Range | 5.76 - 21.00 |
| Beta | 0.02 |
| RSI | 50.94 |
| Earnings Date | Mar 31, 2026 |